PE20030357A1 - Cristales de hidrato de piridinil-metiltio-benzimidazol y procedimiento para su preparacion - Google Patents
Cristales de hidrato de piridinil-metiltio-benzimidazol y procedimiento para su preparacionInfo
- Publication number
- PE20030357A1 PE20030357A1 PE2002000736A PE2002000736A PE20030357A1 PE 20030357 A1 PE20030357 A1 PE 20030357A1 PE 2002000736 A PE2002000736 A PE 2002000736A PE 2002000736 A PE2002000736 A PE 2002000736A PE 20030357 A1 PE20030357 A1 PE 20030357A1
- Authority
- PE
- Peru
- Prior art keywords
- cycloalkyl
- alkyl
- methylthi
- pyridinyl
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A CRISTALES DE HIDRATO DE 2-(2-PIRIDINIL)METILTIO-1H-BENZIMIDAZOL DE FORMULA I DONDE R1, R2, R3 SON H, ALQUILO C1-C8, CICLOALQUILO C3-C8, FLUOROALQUILO C2-C8, ALCOXI C1-C8; R4 Y R5 SON H, ALQUILO C1-C8, CICLOALQUILO C3-C8, CH2-C3-C8-CICLOALQUILO, C2-C8-FLUOROALQUILO, C1-C8 ALCOXI; R4 Y R5 SON H, ALQUILO C1-C8, CICLOALQUILO C3-C8, FLUOROALQUILO C2-C8, ENTRE OTROS; R6 ES H, ALQUILO C1-C2; X ES 0,5-2. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA AISLAR UN COMPUESTO A PARTIR DE UN MEDIO DE REACCION EN EL QUE SE ENCUENTRA EN FORMA DE BASE LIBRE CARACTERIZADO PORQUE UN SOLVENTE ORGANICO MISCIBLE CON AGUA EN EL MEDIO SE ELIMINA PARCIALMENTE, AL MEDIO DE REACCION SE AGREGA A UN TEMPERATURA INFERIOR A 40 ºC AL MENOS 55% DE AGUA CON RELACION AL MEDIO DE REACCION Y LOS HIDRATOS RESULTANTES EN FORMA DE CRISTALES SE SEPARAN Y SE PURIFICAN
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10140492A DE10140492A1 (de) | 2001-08-17 | 2001-08-17 | Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030357A1 true PE20030357A1 (es) | 2003-04-26 |
Family
ID=7695825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000736A PE20030357A1 (es) | 2001-08-17 | 2002-08-15 | Cristales de hidrato de piridinil-metiltio-benzimidazol y procedimiento para su preparacion |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7435825B2 (es) |
| EP (1) | EP1421076B1 (es) |
| AR (1) | AR036263A1 (es) |
| AT (1) | ATE375337T1 (es) |
| CA (1) | CA2457576C (es) |
| DE (2) | DE10140492A1 (es) |
| ES (1) | ES2295389T3 (es) |
| IL (2) | IL160252A0 (es) |
| PE (1) | PE20030357A1 (es) |
| PT (1) | PT1421076E (es) |
| WO (1) | WO2003016301A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7507829B2 (en) | 2002-12-19 | 2009-03-24 | Teva Pharmaceuticals Industries, Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| MXPA05013316A (es) * | 2003-06-10 | 2006-03-17 | Teva Pharma | Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol. |
| US11072651B2 (en) | 2016-09-14 | 2021-07-27 | Beijing Hanmi Pharm. Co., Ltd. | Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibody |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| IL66340A (en) | 1981-08-13 | 1986-08-31 | Haessle Ab | Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation |
| IE53249B1 (en) * | 1981-09-04 | 1988-09-14 | Anderson Cook Inc | Method for making a composite metal-plastic gear |
| JPH0643426B2 (ja) | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
| WO1997029103A2 (en) | 1996-02-06 | 1997-08-14 | Pdi-Research Laboratories, Inc. | Synthesis of omeprazole-type pyridine derivatives and intermediates thereof |
| TW385306B (en) | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
| CA2204580A1 (en) | 1997-05-06 | 1998-11-06 | Michel Zoghbi | Synthesis of pharmaceutically useful pyridine derivatives |
| GB9717107D0 (en) * | 1997-08-12 | 1997-10-15 | Univ Oxford | Organic compound synthesis |
| US6166213A (en) | 1998-08-11 | 2000-12-26 | Merck & Co., Inc. | Omeprazole process and compositions thereof |
| PL333847A1 (en) | 1999-06-18 | 2001-01-02 | Inst Farmaceutyczny | Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form |
-
2001
- 2001-08-17 DE DE10140492A patent/DE10140492A1/de not_active Withdrawn
-
2002
- 2002-08-08 DE DE50211061T patent/DE50211061D1/de not_active Expired - Lifetime
- 2002-08-08 IL IL16025202A patent/IL160252A0/xx unknown
- 2002-08-08 AT AT02758447T patent/ATE375337T1/de active
- 2002-08-08 ES ES02758447T patent/ES2295389T3/es not_active Expired - Lifetime
- 2002-08-08 EP EP02758447A patent/EP1421076B1/de not_active Expired - Lifetime
- 2002-08-08 CA CA2457576A patent/CA2457576C/en not_active Expired - Fee Related
- 2002-08-08 WO PCT/EP2002/008867 patent/WO2003016301A1/de active IP Right Grant
- 2002-08-08 PT PT02758447T patent/PT1421076E/pt unknown
- 2002-08-15 AR ARP020103095A patent/AR036263A1/es unknown
- 2002-08-15 PE PE2002000736A patent/PE20030357A1/es not_active Application Discontinuation
-
2004
- 2004-02-04 US US10/772,033 patent/US7435825B2/en not_active Expired - Fee Related
- 2004-02-05 IL IL160252A patent/IL160252A/en not_active IP Right Cessation
-
2008
- 2008-07-09 US US12/169,813 patent/US7557218B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AR036263A1 (es) | 2004-08-25 |
| CA2457576C (en) | 2010-05-25 |
| PT1421076E (pt) | 2007-11-28 |
| WO2003016301A1 (de) | 2003-02-27 |
| US7435825B2 (en) | 2008-10-14 |
| US7557218B2 (en) | 2009-07-07 |
| CA2457576A1 (en) | 2003-02-27 |
| IL160252A (en) | 2009-06-15 |
| US20040158072A1 (en) | 2004-08-12 |
| EP1421076A1 (de) | 2004-05-26 |
| US20080269497A1 (en) | 2008-10-30 |
| EP1421076B1 (de) | 2007-10-10 |
| DE10140492A1 (de) | 2003-08-14 |
| ATE375337T1 (de) | 2007-10-15 |
| DE50211061D1 (de) | 2007-11-22 |
| ES2295389T3 (es) | 2008-04-16 |
| IL160252A0 (en) | 2004-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE25498A1 (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, procedimientos para su preparacion y la aplicacion de estos compuestos en medicamentos | |
| CO5080782A1 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa | |
| CO5150173A1 (es) | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv | |
| CO5261497A1 (es) | Gama-hidroxi-2-(fluoroalquilamino-carbonil)-1-piperazino pentanamidas y sus usos | |
| CO6190620A2 (es) | Triazoles biciclicos como moduladores de la proteina cinasa | |
| CO6020004A1 (es) | Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c | |
| CA2184919A1 (en) | New Piperazine Derivatives and Methods for the Preparation Thereof and Compositions Containing the Same | |
| CO5210949A1 (es) | Trifluorometilalquilaminotriazolopirimidinas fungicidas | |
| AR048213A1 (es) | 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol | |
| CO5320599A1 (es) | Inhibidores no peptidilicos de la union a las celulas depen dientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| AR044400A1 (es) | Procesos para la preparacion de derivados de pirimidina | |
| EA201070437A3 (ru) | Способ получения 2'-дезокси -5-азацитидина (децитабина) | |
| PE20060650A1 (es) | Metodo para preparar irbesartan e intermediarios del mismo | |
| EA200100310A1 (ru) | Кислородсодержащие гетероциклические соединения | |
| AR045007A1 (es) | Compuestos de quinazolinona sustituidos con arilamina | |
| DK1442006T3 (da) | Fremstilling af amfetaminer fra phenylpropanolaminer | |
| PE20030357A1 (es) | Cristales de hidrato de piridinil-metiltio-benzimidazol y procedimiento para su preparacion | |
| KR860001074A (ko) | 생물학적으로 활성인 질소함유 헤테로시클릭 화합물의 제조방법 | |
| CO5200762A1 (es) | Preparacion de piperidin-4-onas sustituidas | |
| AR051389A1 (es) | Procedimiento e intermediarios de preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n-fenil-metilsulfonamida | |
| CO5070565A1 (es) | Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido y sus composiciones farmaceuticas | |
| BR0116750A (pt) | Método e composições para atrair mosquitos | |
| CO5271656A1 (es) | Procedimiento para la separacion enzimatica de racematos de derivados de aminometil-aril-ciclohexanol | |
| AR069311A1 (es) | Proceso para preparar (r)-5-(2-aminoetil)-1-(6,8-difluorocroman-3-il)-1,3-dihidroimidazol-2-tiona y compuestos intermediarios de sintesis | |
| KR950018011A (ko) | 비스인돌릴말레이미드의 개선된 합성 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |